GW Pharmaceuticals plc provided sales guidance for the fourth quarter and full year ended December 31, 2020. Based on preliminary unaudited financial information, the company expects total net product sales to be approximately $148 million for the fourth quarter. For the full year, the company expects total net product sales to be approximately $526 million.